Crown Bioscience invites you to attend a symposium focusing on in vivo and in vitro solutions for immunotherapy assessment. We have assembled a panel of thought leaders who will present their most innovative data alongside CrownBio´s Scientists who will discuss our I/O platforms, including humanized target knock-in models and in vitro organoid co-cultures and how to apply them to drug development and translational research.
Attend this Symposium to Explore:
- How on-target toxicities caused by systemic administration of antibody drugs can limit their application
- The potential of HUB Organoid Technology in vitro and how tumor organoids can be established, maintained, and applied to precision oncology
- The benefits of patient-relevant 3D in vitro platforms in oncology drug development
Presentations and Speakers
 |
Pan-Chyr YangProfessor, Taiwan University |
 |
Kevin WangVice President, Crown Bioscience Inc. |
 |
Tian-Lu ChengProfessor, Kaohsiung Medical University |
 |
Ying Chih ChangResearcher, Academia Sinica |
 |
Kevin BuyensHead of Corporate Development & Strategy, Crown Bioscience Inc. |
 |
Dr. Xiaoxi XuHead of Organoid Platform, Crown Bioscience Inc. |
 |
Dr. Hongjuan ZhangSenior Scientist of Cancer Biology and Immunology, Crown Bioscience Inc. |
Schedule of Events
| Time | Event |
|---|---|
| 13:30 | 報到 Registration |
| 14:00 | 開場致詞 Opening Remarks 生策會副會長 楊泮池院士 & 中美冠科生物技術有限公司 副總裁王簾讀 Institute for Biotechnology and Medicine Industry(IBMI) Vice President Pan-Chyr Yang, Academician of Academia Sinica, Crown Bioscience Inc. Vice President Kevin Wang |
| 14:10 | 中美冠科新藥研發平台介紹 CrownBio New Drug Research and Development Platform Introduction 中美冠科生物技術有限公司 副總裁王簾讀 Crown Bioscience Inc. Vice President Kevin Wang |
| 14:30 | 以抗體自體絞鍊區當萬能抗體鎖以增加抗體藥物選擇性與安全性 An Autologous Hinge as a Universal Antibody Lock Enhances Antibody Selectivity and Safety 高雄醫學大學 鄭添祿教授 Kaohsiung Medical University Professor Tian-Lu Cheng |
| 15:00 | 腫瘤類器官簡介 Organoid Briefing 中美冠科生物技術有限公司 企業發展和戰略主管Kevin Buyens Crown Bioscience Inc. Head of Corporate Development & Strategy Kevin Buyens |
| 15:10 | 茶敘 Coffee Break & Network |
| 15:40 | 單細胞衍生類器官細胞平台及精準醫學的應用 Single Cell Derived Organoids Toward Precision Medicine 中央研究院 張瑛芝研究員 Academia Sinica Researcher Ying Chih Chang |
| 16:10 | 人源腫瘤類器官在藥物研發和轉化醫學中的應用 Applications of Patient-Derived Cancer Organoids in Drug Development and Translational Research 中美冠科生物技術有限公司 類器官平臺負責人徐小溪博士 Crown Bioscience Inc. Head of Organoid Platform Dr. Xiaoxi Xu |
| 16:40 | 腫瘤類器官在體外免疫共培養中的應用 In vitro Immuno-Oncology and Organoid Co-culture Platforms 中美冠科生物技術有限公司 腫瘤生物學與免疫學高級科學家张红娟博士 Crown Bioscience Inc. Senior Scientist of Cancer Biology and Immunology Dr. Hongjuan Zhang |
Register now to reserve your seat!
